Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1759
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18004556 | Compositions and Methods for Inhibiting and Treating Coronavirus Infections | Non-Final OA | The Regents of the University of California |
| 18208394 | METHODS FOR CHARACTERIZING HOST-CELL PROTEINS | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17439134 | METHODS OF OBTAINING LIPIDS FROM A MICROBIAL CELL COMPOSITION | Final Rejection | DSM IP Assets B.V. |
| 18325470 | DISHWASHING DETERGENT COMPOSITION COMPRISING XYLANASE AND BLOCK CO-POLYMER | Non-Final OA | The Procter & Gamble Company |
| 18747769 | COLLAGEN FIBERS AND ARTICLES FORMED THEREFROM | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 18199277 | FOOD PRODUCTION SYSTEM, COMPOSITIONS, AND METHODS OF USING THE SAME | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18594957 | COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS | Non-Final OA | AgroSpheres, Inc. |
| 18424524 | MOLECULAR PROBES FOR MAPPING BIOLOGICAL ACTIVITY | Final Rejection | Trustees of Boston University |
| 18036474 | COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS | Final Rejection | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| 18278911 | A CLOCK OSCILLATOR FOR BIOCHEMICAL REACTION COMPUTERS | Final Rejection | SOUTH CHINA UNIVERSITY OF TECHNOLOGY |
| 18620513 | COMPOSITION COMPRISING BOTULINUM TOXIN | Non-Final OA | MERZ PHARMA GMBH & CO. KGAA |
| 18606261 | DECELLULARIZED MUSCLE MATRIX | Non-Final OA | LifeCell Corporation |
| 17915652 | SUBMERGED FERMENTATION PROCESS | Final Rejection | Novozymes A/S |
| 17913103 | CLEANING COMPOSITIONS COMPRISING POLYPEPTIDES HAVING FRUCTAN DEGRADING ACTIVITY | Non-Final OA | Novozymes A/S |
| 17992331 | Spray-Dried Tetrasaccharides | Final Rejection | Chr. Hansen A/S |
| 18425886 | OXYGEN SCAVENGERS FOR ELECTROCHEMICAL BIOSENSORS | Non-Final OA | Maria Gabriela Machado de Almeida |
| 18010076 | METHODS FOR TESTING ANDEXANET POTENCY | Final Rejection | Alexion Pharmaceuticals, Inc. |
| 18060134 | METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS | Final Rejection | Research Development Foundation |
| 18541250 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | Final Rejection | Aker BioMarine Human Ingredients AS |
| 17741394 | CHROMATOGRAPHY MEDIUM | Non-Final OA | Cytiva BioProcess R&D AB |
| 18009485 | FLUID GEL COMPOSITIONS | Non-Final OA | The University of Birmingham |
| 18009144 | FLUID GEL COMPOSITIONS | Non-Final OA | The University of Birmingham |
| 18233680 | PROTEASE COMPOSITIONS AND METHODS OF USE | Non-Final OA | Swiss-American CDMO, LLC |
| 18256867 | REGENERATIVE TISSUE MANUFACTURING PROCESS | Non-Final OA | Vascudyne, Inc. |
| 18249545 | COMPOSITION FOR THE TREATMENT OF BIOLOGICAL, CYTOLOGICAL, HISTOLOGICAL AND AUTOPSICAL SAMPLES | Non-Final OA | DIAPATH S.P.A. |
| 18249182 | PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION | Non-Final OA | UNIVERSITE CATHOLIQUE DE LOUVAIN |
| 17998432 | SLOW RELEASE PLASMINOGEN ACTIVATOR FORMULATION FOR USE IN THE TREATMENT OF THROMBOTIC OR HAEMORRHAGIC DISEASE | Final Rejection | OP2LYSIS |
| 17917835 | USE OF VITAMIN K IN PREVENTING OR COUNTERACTING COVID-19 DISEASE AND DIAGNOSTIC TEST TO ESTIMATE THE RISK OF DEVELOPING SEVERE DISEASE OR MORTALITY BY COVID-19 | Final Rejection | Kovit BV |
| 17917754 | TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION | Final Rejection | Laurie E. SOWER |
| 17668108 | DEVICE, METHOD AND SYSTEM FOR MONITORING IMMUNE SYSTEM RESPONSE | Final Rejection | Olaris, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy